IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study

References

• Woo KT, Chan CM, Lim C, et al. A global evolutionary trend of the frequency of primary glomerulonephritis over the past four decades. Kidney Dis. 2019;5(4):247–258.
   Google Scholar
• Li GS, Zhu L, Zhang H, et al. Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy. Hum Mutat. 2007;28(10):950–957.
   PubMed Web of Science ®Google Scholar
• Li GS, Zhang H, Lv JC, et al. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int. 2007;71(5):448–453.
   PubMed Web of Science ®Google Scholar
• Li GS, Nie GJ, Zhang H, et al. Do the mutations of C1GALT1C1 gene play important roles in the genetic susceptibility to Chinese IgA nephropathy? BMC Med Genet. 2009;10:101.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zheng J, Jia J, et al. Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy. Ren Fail. 2019;41(1):370–376.
   PubMed Web of Science ®Google Scholar
• Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014–1021.
   PubMed Web of Science ®Google Scholar
• Inker L, Mondal H, Greene T, et al. Early change in urine protein as a surrogate end point in studies of IgA nephropathy: an individual-patient meta-analysis. Am J Kidney Dis. 2016;68(3):392–401.
   PubMed Web of Science ®Google Scholar
• Shu D, Xu F, Su Z, et al. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study. BMC Nephrol. 2017;18(1):11.
   PubMedGoogle Scholar
• Floege J. Prognostic assessment of IgA nephropathy: how much does histology add? Kidney Int. 2016;89(1):19–21.
   PubMed Web of Science ®Google Scholar
• Li PKT, Ho KKL, Szeto CC, et al. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant. 2002;17(1):64–69.
   PubMed Web of Science ®Google Scholar
• Huang PP, Shu DH, Su Z, et al. Association between lifestyle, gender and risk for developing end-stage renal failure in IgA nephropathy: a case-control study within 10 years. Ren Fail. 2019;41(1):914–920.
   PubMed Web of Science ®Google Scholar
• Rodicio JL. Idiopathic IgA nephropathy. Kidney Int. 1984;25(4):717–729.
   PubMed Web of Science ®Google Scholar
• Van Dixhoorn MG, Sato T, Muizert Y, et al. Combined glomerular deposition of polymeric rat IgA and IgG aggravates renal inflammation. Kidney Int. 2000;58(1):90–99.
   PubMed Web of Science ®Google Scholar
• Wada Y, Ogata H, Takeshige Y, et al. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy. Clin Exp Nephrol. 2013;17(1):73–82.
   PubMed Web of Science ®Google Scholar
• Alvarado AS, Andeen NK, Brodsky S, et al. Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy. Nephrol Dial Transplant. 2018;33(7):1168–1175.
   PubMed Web of Science ®Google Scholar
• Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982;13(4):314–322.
   PubMed Web of Science ®Google Scholar
• Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993;44(2):411–422.
   PubMed Web of Science ®Google Scholar
• Joint Committee for Guideline Revision. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension - a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019;16:182–241.
   PubMedGoogle Scholar
• Wang Y, Wei RB, Su TY, et al. Clinical and pathological factors of anaemia in patients with IgA nephropathy in Chinese adults: a crosssectional study. BMJ Open. 2019;9(1):pe023479.
   Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944.
   PubMed Web of Science ®Google Scholar
• Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–2414.
   PubMed Web of Science ®Google Scholar
• Berger J, Hinglais N. Les dépôts intercapillaries d’IgA-IgG. J Urol Nephrol. 1968;74:694–695.
   PubMedGoogle Scholar
• Odani H, Yamamoto K, Lwayama S, et al. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry. J Nephrol. 2010;23:70–76.
   PubMed Web of Science ®Google Scholar
• HiKi Y, Kokubo T, Lwase H, et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol. 1999;10:760–769.
   PubMed Web of Science ®Google Scholar
• Tomana M, Novak J, Julian BA, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999;104(1):73–81.
   PubMed Web of Science ®Google Scholar
• Novak J, Tomana M, Matousovic K, et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 2005;67(2):504–513.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Fan R, Zhang ZX, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009;119(6):1668–1677.
   PubMed Web of Science ®Google Scholar
• Rizk DV, Saha MK, Hall S, et al. Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1. J Am Soc Nephrol. 2019;30(10):2017–2026.
   PubMed Web of Science ®Google Scholar
• Bellur SS, Troyanov S, Cook HT, et al. Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant. 2011;26(8):2533–2536.
   PubMed Web of Science ®Google Scholar
• Ştefan G, Ismail G, Stancu S, et al. Validation study of Oxford classification of IgA nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining. Pathol Int. 2016;66(8):453–459.
   PubMed Web of Science ®Google Scholar
• Aucouturier P, Monteiro RC, Noël LH, et al. Glomerular and serum lmmunoglobulin G subclasses in IgA nephropathy. Clin Immunol Immunopathol. 1989;51(3):338–347.
   PubMedGoogle Scholar
• Tao MH, Smith RI, Morrison SL. Structural features of human Immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med. 1993;178(2):661–667.
   PubMed Web of Science ®Google Scholar
• Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Choi SY, Jeong KH, et al. Association of C1q deposition with renal outcomes in IgA nephropathy. Clin Nephrol. 2013;80(2):98–104.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Koo HM, Lim BJ, et al. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One. 2012;7(7):e40495.
   PubMed Web of Science ®Google Scholar
• Nam KH, Joo YS, Lee C, et al. Predictive value of mesangial C3 and C4d deposition in IgA nephropathy. Clin Immunol. 2020;211:108331.
   PubMed Web of Science ®Google Scholar
• D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24:179–196.
   PubMed Web of Science ®Google Scholar
• Nieuwhof C, Kruytzer M, Frederiks P, et al. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA Nephropathy. Am J Kidney Dis. 1998;31(6):962–970.
   PubMed Web of Science ®Google Scholar
• Shin DH, Lim BJ, Han IM, et al. Glomerular IgG deposition predicts renal outcome in patients with IgA nephropathy. Mod Pathol. 2016;29(7):743–752.
   PubMed Web of Science ®Google Scholar
• Yoshimura M, Kida H, Abe T, et al. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am J Kidney Dis. 1987;9(5):404–409.
   PubMed Web of Science ®Google Scholar
• Fries JW, Mendrick DL, Rennke HG. Determinants of immune complex-mediated glomerulonephritis. Kidney Int. 1988;34(3):333–345.
   PubMed Web of Science ®Google Scholar
• Lin CY, Chu CM. Studies of circulating immune complexes and lymphocyte subpopulations in childhood IgM mesangial nephropathy. Nephron. 1986;44(3):198–203.
   PubMed Web of Science ®Google Scholar